For the 97 ESCC patients, survival analyses revealed that high infiltration of CD8+ T cells or the presence of mature TLSs was associated with improved patient outcomes (Figure 6F,G). The gene discussed is CD8A; the disease is esophageal squamous cell carcinoma.